Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma

Samuel O. Antwi; William R. Bamlet; Richard M. Cawthon; Kari G. Rabe; Brooke R. Druliner; Hugues Sicotte; Aminah Jatoi; Amit Mahipal; Lisa A. Boardman; Ann L. Oberg; Gloria M. Petersen

doi:10.1158/1055-9965.EPI-20-1279

Research Articles

Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma

Samuel O. Antwi, William R. Bamlet, Richard M. Cawthon, Kari G. Rabe, Brooke R. Druliner, Hugues Sicotte, Aminah Jatoi, Amit Mahipal, Lisa A. Boardman, Ann L. Oberg and Gloria M. Petersen

Samuel O. Antwi

1Division of Epidemiology, Mayo Clinic, Jacksonville, Florida.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Antwi.samuel@mayo.edu

William R. Bamlet

2Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for William R. Bamlet

Richard M. Cawthon

3Department of Human Genetics, University of Utah, Salt Lake City, Utah.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Richard M. Cawthon

Kari G. Rabe

2Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kari G. Rabe

Brooke R. Druliner

4Gastroenterology Laboratory, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Brooke R. Druliner

Hugues Sicotte

2Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aminah Jatoi

5Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amit Mahipal

5Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Amit Mahipal

Lisa A. Boardman

6Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lisa A. Boardman

Ann L. Oberg

2Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ann L. Oberg

Gloria M. Petersen

7Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1055-9965.EPI-20-1279 Published January 2021

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

Cancer Epidemiology Biomarkers & Prevention: 30 (1)

January 2021
Volume 30, Issue 1

Table of Contents
Table of Contents (PDF)
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma

Message Subject (Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention

Message Body (Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma

Samuel O. Antwi, William R. Bamlet, Richard M. Cawthon, Kari G. Rabe, Brooke R. Druliner, Hugues Sicotte, Aminah Jatoi, Amit Mahipal, Lisa A. Boardman, Ann L. Oberg and Gloria M. Petersen

Cancer Epidemiol Biomarkers Prev January 1 2021 (30) (1) 210-216; DOI: 10.1158/1055-9965.EPI-20-1279

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma

Samuel O. Antwi, William R. Bamlet, Richard M. Cawthon, Kari G. Rabe, Brooke R. Druliner, Hugues Sicotte, Aminah Jatoi, Amit Mahipal, Lisa A. Boardman, Ann L. Oberg and Gloria M. Petersen

Cancer Epidemiol Biomarkers Prev January 1 2021 (30) (1) 210-216; DOI: 10.1158/1055-9965.EPI-20-1279

Share This Article: